New cancer clinical trial: NIMBUS: A Phase II Study of Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer

Published on: December 28, 2018 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share